RISK OF STROKE IN NONRHEUMATIC ATRIAL-FIBRILLATION

被引：14
|
作者：
FLEGEL, KM [1 ]
SHIPLEY, MJ [1 ]
ROSE, G [1 ]
机构：
[1] UNIV LONDON LONDON SCH HYG & TROP MED,DEPT EPIDEMIOL,LONDON WC1E 7HT,ENGLAND
来源：
LANCET | 1987年 / 1卷 / 8532期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：526 / 529
页数：4
相关论文
共 50 条
  • [21] RISK-FACTORS FOR STROKE IN PATIENTS WITH NONRHEUMATIC ATRIAL-FIBRILLATION - A CASE-CONTROL STUDY
    MOULTON, AW
    SINGER, DE
    HAAS, JS
    AMERICAN JOURNAL OF MEDICINE, 1991, 91 (02): : 156 - 161
  • [22] ATRIAL-FIBRILLATION - RISK MARKER FOR STROKE
    CHESEBRO, JH
    FUSTER, V
    HALPERIN, JL
    NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (22): : 1557 - 1558
  • [23] NONRHEUMATIC ATRIAL-FIBRILLATION - WARFARIN OR ASPIRIN FOR ALL
    NOLAN, J
    BLOOMFIELD, P
    BRITISH HEART JOURNAL, 1992, 68 (06): : 544 - 547
  • [24] SECONDARY PREVENTION IN NONRHEUMATIC ATRIAL-FIBRILLATION AFTER TRANSIENT ISCHEMIC ATTACK OR MINOR STROKE
    KOUDSTAAL, PJ
    DEHAENE, I
    DHOOGHE, M
    MARCHAU, M
    VANZANDIJCKE, M
    DELWAIDE, C
    DEPRE, A
    LATERRE, EC
    VANBUGGENHOUT, E
    SCHURMANS, J
    DESMET, E
    SWERTS, L
    VANDENABEELE, G
    CARTON, H
    VERDRU, PMA
    INDEKEU, PA
    LAM, D
    VANDENBERGH, V
    VANLANDEGEM, W
    STRAUVEN, T
    BOYSEN, G
    GYRING, J
    PETERSEN, P
    WURTZENNIELSEN, P
    CREPINLEBLOND, T
    MOULIN, T
    AURIACOMBE, S
    ORGOGOZO, JM
    BOULLIAT, J
    GOAS, JY
    MOCQUARD, Y
    BESSON, G
    HOMMEL, M
    ADNETBONTE, C
    JOSIEN, E
    CHEDRU, F
    EVRARD, S
    LEVASSEUR, M
    MAS, JL
    MEYNIARD, O
    ZUBER, M
    AMARENCO, P
    BOUSSER, MG
    ROULLET, E
    PINEL, JF
    MASSARDIER, E
    MIHOUT, B
    CHOLLET, F
    RASCOL, A
    AUTRET, A
    LANCET, 1993, 342 (8882): : 1255 - 1262
  • [25] PREDICTION OF EARLY DEVELOPMENT OF CHRONIC NONRHEUMATIC ATRIAL-FIBRILLATION
    SAKAMOTO, H
    OKAMOTO, EI
    IMATAKA, K
    IEKI, K
    FUJII, J
    JAPANESE HEART JOURNAL, 1995, 36 (02): : 191 - 199
  • [26] ANTITHROMBOTIC THERAPY PRESCRIBED FOR PATIENTS WITH NONRHEUMATIC ATRIAL-FIBRILLATION
    HENDRY, A
    CAMPBELL, AM
    CAMPBELL, G
    MACDONALD, JB
    WILLIAMS, BO
    SCOTTISH MEDICAL JOURNAL, 1994, 39 (04) : 110 - 111
  • [27] TRANSESOPHAGEAL ECHOCARDIOGRAPHIC DETERMINANTS OF EMBOLISM IN NONRHEUMATIC ATRIAL-FIBRILLATION
    MITUSCH, R
    LANGE, V
    STIERLE, U
    MAURER, B
    SHEIKHZADEH, A
    INTERNATIONAL JOURNAL OF CARDIAC IMAGING, 1995, 11 (01): : 27 - 34
  • [28] IS ATRIAL-FIBRILLATION AN INDEPENDENT RISK FACTOR FOR STROKE
    PHILLIPS, SJ
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1990, 17 (02) : 163 - 168
  • [29] ORAL ANTICOAGULATION FOR PREVENTION OF THROMBOEMBOLISM IN NONRHEUMATIC ATRIAL-FIBRILLATION - INDICATIONS, EFFICACY, AND RISK
    KOTTKAMP, H
    WILLEMS, S
    HINDRICKS, G
    CHEN, X
    HAVERKAMP, W
    HASFELD, M
    BORGGREFE, M
    BREITHARDT, G
    ZEITSCHRIFT FUR KARDIOLOGIE, 1993, 82 (11): : 667 - 673
  • [30] ATRIAL-FIBRILLATION - EPIDEMIOLOGY AND THE RISK AND PREVENTION OF STROKE
    KALMAN, JM
    TONKIN, AM
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1992, 15 (09): : 1332 - 1346
12345